SOLICITATION NOTICE
65 -- Notice of Intent to Award a Sole Source - NextSeq™ 500 High Output Reagents Kit (300 cycles)
- Notice Date
- 12/8/2014
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 3900 NCTR Road, HFT-320, Bldg 50 | Rm 421, Jefferson, Arkansas, 72079, United States
- ZIP Code
- 72079
- Solicitation Number
- FDA1142976
- Archive Date
- 1/7/2015
- Point of Contact
- Janice Heard, Phone: 215-717-3093
- E-Mail Address
-
janice.heard@fda.hhs.gov
(janice.heard@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- Notice of Intent to Award a Sole Source Contract - FDA1142976 Description(s): NextSeq TM 500 High Output Reagents Kit (300 cycles) The Food and Drug Administration, intends to make a sole source award to Illumina for NextSeq High Output Reagents. The laboratory analyzes metagenome samples using NextSeq 500 sequencer. Illumina sequencing kits use an all-inclusive reagent cartridge system that is specifically designed to deliver the reagents necessary for cluster generation, sequencing, and paired-end chemistry. In addition, the NextSeq 500 system uses a flow cell that is specifically designed for the instrument. Illumina is the only manufacturer who can provide these reagent kits compatible with the NextSeq 500 sequencer instrument that we have in our laboratory. The period of performance will be for a total of 48 months with an IDIQ type of contract anticipated. The NAICS Code for this action is 541711. This procurement is made under the authority of 10 USC 2304(c) (1)- only one responsible source. This is a notice of intent to issue this solicitation on a sole source basis. This notice of intent is not a solicitation for competitive proposals. Any other firms desiring consideration must fully identify their interest and capability to provide this item, or submit a proposal within 15 days to the individual listed. A determination by the Government not to compete the proposed contract based upon responses to this notice is solely within the discretion of the Government. The projected award date is on or about February 17, 2015. Primary Point of Contact: Janice Heard Contract Specialist Janice.Heard@fda.hhs.gov Phone: 215-717-3093 Contracting Office Address: 200 Chestnut Street, Rm 900 U.S. Customhouse Philadelphia, PA 19106
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/NCTR/FDA1142976/listing.html)
- Place of Performance
- Address: Food & Drug Administration, 8401 Muirkirk Road, Laurel, Maryland, 20708, United States
- Zip Code: 20708
- Zip Code: 20708
- Record
- SN03590007-W 20141210/141208234346-18beb21cb1ace3709729f54fc5fe25a8 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |